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Abstract
Background: Duplex real-time PCR assays have been widely used to determine amounts and concentrations of free
circulating DNA in human blood plasma samples. Circulatory plasma DNA is highly fragmented and hence a PCR-based
determination of DNA concentration may be affected by the limited availability of full-length targets in the DNA sample.
This leads to inaccuracies when counting PCR target copy numbers as whole genome equivalents.
Methodology/Principal Findings: A model system was designed allowing for assessment of bias in a duplex real-time PCR
research assay. We collected blood plasma samples from male donors in pools of 6 to 8 individuals. Circulatory plasma DNA
was extracted and separated by agarose gel electrophoresis. Separated DNA was recovered from the gel in discrete size
fractions and analyzed with different duplex real-time PCR Taqman assays detecting a Y chromosome-specific target and an
autosomal target. The real-time PCR research assays used differed significantly in their ability to determine the correct copy
number ratio of 0.5 between Y chromosome and autosome targets in DNA of male origin. Longer PCR targets did not
amplify quantitatively in circulatory DNA, due to limited presence of full-length target sequence in the sample.
Conclusions: PCR targets of the same small size are preferred over longer targets when comparing fractional circulatory
DNA concentrations by real-time PCR. As an example, a DYS14/18S duplex real-time PCR research assay is presented that
correctly measures the fractional concentration of male DNA in a male/female mixture of circulatory, fragmented DNA.
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Introduction
Real-time PCR assays have become a widely used method for
absolute quantitation of free circulating DNA in plasma or serum
samples as the concentration of circulating DNA can be too low
for accurate spectrophotometric measurements [1]. Typically, the
amplification of one or a few target sequences in a real-time PCR
assay is used to quantify the target DNA molecules by comparing
the amplification signal of the unknown sample to a standard
curve with known DNA concentration [2]. In the case of
circulatory DNA, the concentration of the sample is usually
determined by comparing the sample to a standard which is made
up of high-quality genomic DNA. The concentration of this
quantitation standard is, in most cases, determined by measuring
UV absorbance. Circulating DNA in plasma, however, is known
to be highly fragmented with a majority of the fragments being
shorter than 500 bp [1,3]. This raises the question if circulatory,
fragmented DNA can be accurately quantitated by real-time PCR
when high-quality genomic DNA is used as a quantitation
reference. DNA fragmentation leads to a lower availability of
intact target sequences compared to high quality genomic DNA
such that, in a circulatory DNA sample, it may be no longer
possible to determine the number of diploid or haploid genome
equivalents from the detected number of target sequences.
In spite of these technical challenges, the quantitative analysis of
circulating DNA is gaining increased importance as a tool of
molecular diagnostics addressing various conditions [1]. Circulat-
ing DNA derived from tumors can be detected in plasma or serum
and the concentration of a tumor-specific target region (e.g., a
mutation or a tumor-specific methylation pattern) may reveal
details about the malignant condition. Also, measurements of local
variations in gene copy numbers can be performend in circulating
DNA and the correct measurement of a copy number variation
relative to a reference region by real-time PCR hinges on the use
of a non-biased quantitative PCR assay. A reliable determination
of the quantities of different DNA targets is important as well in
the analysis of circulating fetal DNA in the plasma of a pregnant
woman. In a situation where a duplex real-time PCR assay or two
separate singleplex assays are used to compare abundances of two
different target regions in a sample of fragmented DNA, it is
crucial that the quantitative detection of the two targets is not
influenced by different degrees of degradation of the target DNA
sequences—leading to incorrect quantities of the respective target.
One example where this may cause biased results is the
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total circulating DNA present in maternal plasma where the fetal
DNA is detected by a real-time PCR assay specific for a Y
chromosome locus (in women carrying a male fetus) and, likewise,
total human DNA is measured by targeting an autosomal locus
[4]. Correct, non-biased quantification of fragmented DNA is also
important in forensic analysis of human DNA. An example is the
determination of male DNA content of a case work DNA sample
where male and total human DNA are quantitatively detected by a
duplex real-time PCR assay in order to determine the percentage
of male DNA in the sample [5].
Materials and Methods
We have tested three different duplex real-time PCR assays for
potential quantitation bias in samples of circulatory DNA extracted
from plasma of adult, healthy male and female volunteers. Ethics
Statement:Allblooddonationvolunteersdonatedbloodsampleswith
informed consent after Review Board approval (A ¨rztekammer
Nordrhein/North Rhine Chamber of Physicians, 40474 Du ¨sseldorf,
Germany, case number 2007389). Blood samples were separated by
the donor’s gender and otherwise processed and stored anonymously.
In a first set of experiments, whole EDTA blood was collected
from male donors. Blood samples were obtained by venipuncture
and collected into 10 ml EDTA Plus Vacutainer tubes (Becton
Dickinson, Heidelberg, Germany). Plasma was prepared within 30
min after blood draw by centrifugation for 10 min at 1800 N g,
followed by careful aspiration of the plasma supernatant. Plasma
from six to eight individuals was pooled, frozen, and stored below
220uC until further processing. Before DNA extraction, thawed
plasma samples were again centrifuged for 15 min at 5500 N g. The
plasma supernatant was carefully removed to fresh tubes, kept on
ice, and used for DNA extraction within 20 minutes. Circulatory
DNA was extracted from 60 mL of plasma using a variation of the
QIAamp DNA Blood Midi protocol (QIAGEN GmbH, Hilden,
Germany): 10 ml plasma was processed per one QIAamp Mini
column using a 20 ml tube extender, 10 ml of buffer AL was used
per 10 ml of plasma. After sample lysis, 12 ml of ethanol was
added. DNA was eluted in 100 ml buffer EB per column. Eluted
DNA from up to six columns was pooled, precipitated with
ethanol/sodium acetate, dissolved in 15 ml buffer EB and stored at
220uC until further processing.
DNA concentration of these samples was determined by UV
absorbance reading on a NanoDrop spectrophotometer (Nano-
Drop Technologies, Wilmington, DE, USA).
DNA extracted from 10 ml plasma as described above was
separated on a 1% agarose gel run at 120–130 mV for 1 h. The
whole gel lane from the loading slot to a DNA fragment size of
<70 bp was cut into slices as described in ref. [2] and as indicated
in fig. 1A. The DNA was recovered from the gel slices using the
QIAquick gel extraction kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s handbook and each gel slice
was eluted in 100 ml buffer EB (QIAGEN). The DNA in the
recovered size fractions was analyzed using different duplex real-
time PCR assays in order to check for DNA quantity and the Y-
chromosome to autosome ratio.
In a second experiment, circulatory DNA extracted from plasma
pools obtained from adult healthy male and female donors,
respectively, was mixed to yield female circulatory DNA with a
defined proportion of male DNA. The mixtures were subjected to
analysis by duplex real-time PCR [6,7] in order to obtain the
measured percentage of maleDNA for each given percentage of male
DNA. The measured male DNA percentage was plotted against the
given percentage and a linear regression analysis was performed with
the equation y = b N x + a, with y = percentage of male DNA
(measured), x = percentage of male DNA (given), b = slope (assay
bias), a = intercept. The three assays were analyzed for statistically
significant differences as shown in Supporting Information File S1.
Real-time PCR using Taqman probes was performed on an
ABI7500 instrument (Applied Biosystems, Foster City, CA)
targeting the following genes: DYS14 (synonyme for testis-specific
protein 1), c-myc (synonyme for v-myc myelocytomatosis viral
oncogene homolog), SRY (sex determining region Y), 18S (18S
ribosomal RNA cio ´ding sequence). Design of duplex real-time
PCR Assays: Assay 1 – DYS14/18S-1 (66 bp/67 bp PCR product
size), Assay 2 – SRY-1[8]/c-myc (78 bp/81 bp), Assay 3 – SRY-2/
18S-2 (91 bp/187 bp). Further assay and oligonucleotide details
are available as Supporting Information File S2.
Results and Discussion
The size distribution of circulatory plasma DNA separated by
agarose gel electrophoresis is shown in fig. 1A: The three duplex
assays detected Y-chromosome sequences (SRY, DYS14) and
autosomal sequences (c-myc, 18S-1, 18S-2). More than 2/3 of the
circulatory DNA present in plasma was of less than 500 bp in size,
as detected by SRY and DYS14. Less than 1 % of the fragments
were longer than 10 kB. Assay 1 (DYS14/18S-1) showed that the
calculated copy numbers for 18S were roughly twice as high as for
DYS14 in all fractions. Assay 2 (SRY-1/c-myc) showed a similar
pattern, except for the fraction of ,300 bp DNA where the copy
numbers obtained for both targets were virtually identical. Assay 3
(SRY-2/18S-2) showed a lower copy number for 18S in the
fractions ,500 bp, so that the ratio of SRY to 18S copies was
reversed in those fractions.
The three presented duplex Taqman assays were used to
determine absolute quantities of target DNA sequences with
interpreting the resulting target copy numbers as representative for
a whole genome, i.e. as haploid genome equivalents. The
threshold cycle (Ct) values obtained in DNA samples to be
measured were converted to copy numbers by comparison to a
calibration standard made of male high molecular weight genomic
DNA. In cases where the length of the majority of fragments is
close to the length of the used real-time PCR target sequences, it
follows that a significant part of the target amplicon sequences in
the sample is not present as intact, full-length sequence, leading to
an under-quantification of the respective target sequence (a model
calculation is given in Supporting Information File S3). This can
be observed clearly in fig. 1A, Assay 3: In DNA of less than 300
bp, the detected copy numbers for 18S were strongly reduced,
leading to a considerable deviation from the correct SRY-to-18S
ratio of 1:2 in fractions of DNA ,500 bp. For the SRY/c-myc
assay (Assay 2), a similar effect was observed, albeit not as strong.
Here, the copy numbers for c-myc appeared to be underestimated
in DNA ,300 bp when compared to the SRY signal. Assay 1
(DYS14/18S) delivered an unbiased measurement of the DYS14/
18S ratio of 1:2 in all DNA size fractions.
Testing the duplex Taqman assays in the defined male/female
mixtures of circulatory DNA (fig. 1B), revealed that Assay 1
estimated the male/female ratio correctly as evidenced by a
regression slope b=1.0. In contrast, the determination of the
male/female ratio in both Assay 2 and Assay 3 was significantly
different from the expected ratio (as determined by statistical
analysis—see Supporting Information File S1) and showed a bias
in favor of the Y-chromosome signal. This bias was measured by
the slopes of regression curves of Assay 2 (b=2.9) and Assay 3
(b=5.8), which indicate a 2.9-fold and 5.8-fold overestimation of
the male DNA content in the sample, respectively. It was also
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PLoS ONE | www.plosone.org 2 September 2009 | Volume 4 | Issue 9 | e7207Figure 1. Comparison of three duplex, real-time PCR assays for quantification of circulating plasma DNA. Panel A: Gel-fractionated
plasma circulatory DNA from male donors quantified by three different duplex real-time PCR assays. DNA quantities are expressed as haploid genome
copies by comparison to a genomic DNA standard curve. Dark columns: Y chromosomal amplicon, light column: autosomal amplicon. The data
points represent the mean values +/2 one standard deviation calculated from two gel fractionations with four PCR replicates each per DNA fraction
(n=8 data points). Panel B: Mixtures of male and female circulatory DNA. The proportion of male DNA measured by three duplex real-time PCR assays
(Y axis) was plotted against the given proportion of male DNA (x axis). Data points represent the mean values of two PCR runs with four replicates per
PCR. Error bars correspond to +/2 one standard deviation. The curves were fitted using linear regression analysis. The regression curve of an ideal
assay, i.e., an assay which measures the male/female DNA ratio correctly, would have the slope b=1. A significant deviation of the slopes of assay 2
and 3 from the ideal assay was confirmed by statistical analysis (details shown in Supporting Information File 2). The equations and regression
coefficients for the curve fits are shown next to the respective plot.
doi:10.1371/journal.pone.0007207.g001
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target copy numbers compared to the two other duplex assays as
shown by lower standard deviations.
The underestimation of copy numbers in low molecular weight
DNA can be explained partly by the different lengths of the target
amplicons used. The 18S-1 assay detects a 67 bp target whereas the
18S-2 assay detects a 187 bp target. We expect that in DNA of less
than 300 bp, the number of available full-length 187 bp target
sequences is reduced to less than 38 % when assuming that the
DNA fragments were generated by random cuts (see Supporting
Information File S3). This phenomenon has been used previously to
determine the lengths of DNA fragments in circulatory DNA by
comparing the amplification of targets of different lengths [9,10].
However, the target sequence length alone does not fully determine
the number of available targets in a sample. This suggests the
occurrence of non-random DNA cuts in the process of generating
the population of circulatory plasma DNA, possibly along
nucleosome boundaries. This has been discussed in connection
with the proposal that circulatory DNA is generated during
apoptosis [11,12]. A combination of site-specific and random
endonucleolytic DNA degradation is likely to generate circulatory
plasma DNA. Hence, it is not a given that two different target
sequences of the same length produce identical copy numbers in a
duplex real-time PCR assay (as evidenced by Assay 2 in our study).
Here we present, with the DYS14/18S-1 assay, a duplex real-
time PCR assay using Taqman probes that allows for unbiased
quantification of the Y chromosome to autosome ratio in a
sample of circulatory DNA prepared from plasma. This was
shown in size-fractionated male circulatory DNA and in male/
female mixtures of circulatory DNA where the given proportion
of male DNA is measured correctly. This assay should also be
suitable to quantitate the percentage of male DNA in a forensic
sample. Furthermore, this assay could be used to measure the
percentage of male fetal DNA in maternal plasma. Using the
multicopy DYS14 locus as a real-time PCR target for measuring
the amount of fetal DNA in maternal plasma has been reported
to be superior to a single-copy locus as SRY in terms of sensitivity
and accuracy [13]. Our results confirm these findings. Recently,
it has been demonstrated that microfluidics digital PCR provides
an advantage over real-time quantitative PCR in terms of
accuracy and precision when measuring the fractional concen-
tration of male DNA in male/female DNA mixtures [14].
However, the key experiments of the study used genomic DNA
prepared from tissue and blood cells as sample material and as
material for quantitation standards and not fragmented circu-
lating DNA prepared from plasma as in the work presented here.
I tw o u l db eo fi n t e r e s tt oe l u c i d a t et h ep e r f o r m a n c eo f
microfluidics digital PCR with samples of fragmented circulating
plasma DNA in future studies.
Whenever circulating DNA is analyzed, copy numbers derived
from a real-time PCR assay with fragmented DNA as a template
cannot easily be interpreted as haploid whole genome equivalents
because the real-time PCR assay counts only the copies of
available full length target. This implies that the detected copy
number is, in fact, dependent on the real-time PCR assay
performed. Moreover, the target sequences should be as short as
possible, as has been shown for the analysis of gene expression
levels using partially degraded RNA [15] and CMV viral lead
measurements [16]. Therefore, target copy numbers obtained for
the same sample using different assays should only be compared
after performing appropriate tests that check for quantification
bias, e.g. similar to the experiments presented in this paper.
Supporting Information
Supporting Information File S1 Statistical analysis of results.
Found at: doi:10.1371/journal.pone.0007207.s001 (0.03 MB
PDF)
Supporting Information File S2 Real-time PCR assay details.
Found at: doi:10.1371/journal.pone.0007207.s002 (0.01 MB
PDF)
Supporting information File S3 Model calculation of the
number of target sequences available for amplification.
Found at: doi:10.1371/journal.pone.0007207.s003 (0.01 MB
PDF)
Acknowledgments
We thank Dr. Betty Dragon, Dr. Dirk van den Boom, Paul Oeth, and Dr.
Christoph Ritt for stimulating discussions about the experimental results
presented here. We are also grateful to D.v.d.B. and P.O. for sharing
reagents. We like to thank Dr. Holger Engel for providing helpful critical
comments on the manuscript.
The described methods are intended for research applications. No claim or
representation is intended for its use to provide information for the
diagnosis, prevention, or treatment of a disease.
Author Contributions
Conceived and designed the experiments: MH AL MSH. Performed the
experiments: AL. Analyzed the data: MH AL MSH. Contributed
reagents/materials/analysis tools: MH. Wrote the paper: MH.
References
1. Swarup V, Rajeswari MR (2007) Circulating (cell-free) nucleic acids – A
promising non-invasive tool for early detection of several human diseases. FEBS
Lett 581: 795–799.
2. Yun JJ, Heisler LE, Hwang, IIL, Wilkins O, Lau SK, et al. (2006) Genomic
DNA functions as a universal external standard in quantitative real-time PCR.
Nucleic Acids Res 34: e85.
3. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S (2004) Size
Separation of Circulatory DNA in Maternal Plasma Permits Ready Detection of
Fetal DNA Polymorphisms. Clin Chem 50: 1002–1011.
4. Hromandnikova I, Zejskova L, Doucha J, Codl D (2006) Quantification of Fetal
and Total Circulatory DNA in Maternal Plasma Samples Before and After Size
Fractionation by Agarose Gel Electrophoresis. DNA Cell Biol 25: 635–640.
5. Nicklas JA, Buel E (2006) Simultaneous Determination of Total Human and
Male DNA Using a Duplex Real-Time PCR Assay. J Forensic Sci 51:
1005–1015.
6. Hein AE, Bodendorf U (2007) Real-time PCR: Duplexing without optimization.
Anal Biochem 360: 41–46.
7. Ishii T, Sootome H, Shan L, Yamashita K (2007) Validation of universal
conditions for duplex quantitative reverse transcription polymerase chain
reaction assays. Anal Biochem 362: 201–212.
8. Zhong XY, Holzgreve W, Hahn S (2001) Risk free simultaneous prenatal
identification of fetal Rhesus D status and sex by multiplex real-time PCR using
cell free fetal DNA in maternal plasma. Swiss Med Wkly131: 70–74.
9. Allen Chan KC, Zhang J, Hui ABY, Wong N, Lau TK, Leung TN, et al. (2004)
Size distributions of Maternal and Fetal DNA in Maternal Plasma. Clin Chem
50: 88–92.
10. Kiode K, Sekizawa A, Iwasaki M, Matsuoka R, Honma S, et al. (2005)
Fragmentation of cell-free fetal DNA in plasma and urine of pregnant women.
Prenat Diagn 25: 604–607.
11. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM
(2006) Cell-Free Plasma DNA: A Marker for Apoptosis during Hemodialysis.
Clin Chem 52: 523–526.
12. van der Vaart M, Pretorius PJ (2007) The Origin of Circulating Free DNA.
[Letter]. Clin Chem 53: 2215.
13. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S (2005)
Optimized Real-Time Quantitative PCR Measurement of Male Fetal DNA in
Maternal Plasma. Clin Chem 51: 1598–1604.
14. Lun FMF, Chiu, RWK, Chan CA, Leung, TY, Lau, TK, Lo, YMD (2008)
Microfluidics Digital PCR Reveals a Higher than Expected Fraction of Fetal
DNA in Maternal Plasma. Clin Chem 54: 1664–1672.
Circulating DNA Quantification
PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e720715. Antonov J, Goldstein DR, Oberli A, Baltzer A, Pirotta M, et al. (2005) Reliable
gene expression measurements from degraded RNA by quantitative real-time
PCR depend on short amplicons and a proper normalization. Lab Invest 85:
1040–1050.
16. Boom R, Sol CJA, Schurrman T, van Breda A, Weel JFL, et al. (2002) Human
Cytomegalovirus DNA in Plasma and Serum Specimens of Renal Transplant
Recipients Is Highly Fragmented. J Clin Microbiol 40: 4105–4113.
Circulating DNA Quantification
PLoS ONE | www.plosone.org 5 September 2009 | Volume 4 | Issue 9 | e7207